Pituitary Adenomas

Pituitary adenomas (PA) are a common type of endocrine neoplasia that is usually benign. PA have a high rate of clinical morbidity due to hormonal hypersecretion, neurological symptoms from cerebral mass effects or invasion of adjacent structures, and secondary hypopituitarism. Pharmacological treatment, primarily dopamine agonists (DA) and somatostatin analogues (SSA), surgery, and radiotherapy are being used to treat them [2]. Despite substantial progress in the treatment of PA, a significant portion of individuals remain uncontrollably ill. Long-term uncontrolled pituitary hormone hypersecretion, which can lead to serious systemic illnesses as well as tumour recurrence or aggressiveness, is still a difficult clinical problem.



 


    Related Conference of Pituitary Adenomas

    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Pituitary Adenomas Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in